CD19 and neoplasm: Although no visual radioactivity difference appeared between CD19‐positive and negative tumours, Patlak modelling analysis revealed the specific uptake of CAR T cells targeting CD19 in CD19‐positive solid tumours compared with CD19‐negative tumours.